COMEDISEOUL, COORDINATED WITH CARE.
Talk to your concierge
行程與旅行準備
AI 編輯圖像 / 非實際地點或客戶紀錄
← COMEDI JOURNAL

Is Rejuran worth it in Seoul? What to know before you book

“Everyone says I have to try Rejuran in Korea. Is it really that good?”

Rejuran is worth considering if you want smoother texture and softer fine lines, and you are happy for the change to build slowly. It is not a one-visit makeover. Korean clinics usually plan it as a short course, so the real question for a traveller is less “does it work?” and more “how does it fit my dates?”

COMEDI editorial · Updated 2026-10-11

1. What does Rejuran actually do?

Rejuran is a Korean skin booster made from a DNA-derived ingredient from salmon (polynucleotides). It is injected into the upper layer of the skin to improve the skin itself: texture, fine lines and firmness.

It does not add volume the way filler does. That is why it suits some concerns better than others:

  • Usually a good match: rough texture, fine lines around the eyes and cheeks, skin that looks tired or thin
  • Usually not the answer: hollow cheeks, a dropped jawline, wanting a visible lift

Knowing which side your concern falls on makes the consultation much more useful.

2. How much difference has research found?

Studies consistently report gradual improvement in fine lines, texture and firmness. A 2024 systematic review gathered nine studies of this type of injection, involving 219 people, and several found better wrinkles, texture and elasticity. Seven of the nine were done in Korea.

Timing matters too. A 2026 study followed 42 people who had under-eye injections of the same type. Their satisfaction rose after the first session, peaked about three months after the second, and eased a little by six months. That study used a different brand, but it gives a realistic picture: the result shows up over months, not overnight.

*Based on published research. Results and recovery vary from person to person.

3. How many sessions do Korean clinics recommend?

The most common recommendation is three sessions, four weeks apart. In a 2023 survey of 235 Korean board-certified dermatologists, 88% said they use this type of injection, and three sessions at four-week intervals was the schedule they recommended most.

About eight in ten of them (79%) also pair it with device treatments such as radiofrequency or ultrasound lifting (HIFU). So when two clinics quote very different prices, check first whether you are comparing Rejuran alone or a combined package.

*Based on published research. Results and recovery vary from person to person.

4. I’m only in Seoul for a week. What then?

A one-week trip won’t cover a full course, and that is fine as long as you plan for it. Most visitors end up choosing one of three routes:

  • Start in Seoul, continue at home: have the first session here and finish the course with a clinic near you
  • Come back: return to Seoul about four weeks later for the next session
  • Try once: have a single session and see how your skin responds before committing

Which route suits you depends on your skin and your calendar, so raise it before you book flights. And because the change is clearest a few months later, take a few well-lit photos before treatment. You will want them for comparison once you are home.

5. Why the evidence is promising but not settled

To be candid, Rejuran’s evidence is thinner than its popularity suggests. The 2024 review rated its own studies as low to moderate quality and called for more rigorous research.

One detail rarely makes it into marketing. The 2014 Korean trial that compared this type of injection head-to-head with hyaluronic acid filler was retracted in 2016 because it did not disclose manufacturer funding, yet the review still counts it. Another paper the review cites was retracted in 2024 over its photographs.

That doesn’t mean Rejuran doesn’t work. It means phrases like “better than filler” or “guaranteed regeneration” are ahead of the evidence, and a natural, gradual change is the fair expectation.

6. What to ask at the consultation

Consultations are often shorter than you expect, so bring your questions written down:

  • Is the product and amount the same as in my quote?
  • How many sessions do you recommend for my skin, and what if I can only do one here?
  • Does the price include numbing, any device treatment and a follow-up?
  • What reactions are normal over the next few days, and when should I contact you?
  • How can I reach you from abroad if I have a question?

Because the ingredient comes from salmon, mention any fish allergy right at the start. COMEDI can help you prepare these questions and compare clinics on the same terms; whether to go ahead is decided with the clinician who examines you.

7. The bottom line

Rejuran is a reasonable choice if you want gradual improvement in texture and fine lines and can plan for more than one session. Set your expectations at a natural change, not a dramatic one, and build the plan around the dates you actually have.

常見問題

Does one Rejuran session make a difference?

One Rejuran session can make a noticeable difference for some people, and in the under-eye study improvement began after the first session. Still, the schedule Korean dermatologists recommend most is three sessions four weeks apart, and satisfaction in that study peaked after the second. If one visit is all you can manage, say so early.

Does Rejuran hurt, and will I swell?

Rejuran can leave the treated area briefly sore, swollen, red, itchy or bruised. In the studies collected by the 2024 review, these reactions usually settled within a week and no serious side effects were reported. The studies were small, so plan a day or two without important photos or events and ask what is normal for you.

Is Rejuran safer than filler?

There isn’t enough evidence to say Rejuran is safer than filler, because the main trial comparing the two was retracted. They also solve different problems, so the more useful first question is which one fits your concern.

EVIDENCE / SCOPE & LIMITS

論文,以及它們能告訴我們的事

已查核此處所用說法的原始出處。這些文獻閱讀筆記說明的是文獻研究的範圍,並非全面性的系統性搜尋。每篇論文的閱讀範圍皆已註明。

[S1] Lampridou S, Bassett S, Cavallini M, Christopoulos G. The Effectiveness of Polynucleotides in Esthetic Medicine: A Systematic Review. J Cosmet Dermatol. 2024;24(2):e16721. ↗

2024 · DOI: 10.1111/jocd.16721

Systematic review; 9 studies, 219 patients, 7 of 9 in Korea; quality rated low to moderate; no meta-analysis. Reported adverse events were mild (pain, swelling, itching, bruising, redness), typically resolving within a week. Includes a study later retracted (S2) and cites a retracted paper (S3). Authors disclose ties to the manufacturer Mastelli and a distributor. PARTIAL review.

[S2] Notice of Retraction: Pak CS et al., Polynucleotide Filler and Hyaluronic Acid Filler in the Correction of Crow's Feet. J Korean Med Sci. 2016;31(2):330. ↗

2016

Retraction notice. The 2014 trial misreported its conflict of interest and funding sponsor; it was funded by the filler's manufacturer and a co-author was a company researcher. FULL reading of the notice.

[S3] Retraction: Cavallini M et al., PN-HPT in facial middle third rejuvenation. J Cosmet Dermatol. 2024. ↗

2024

Retracted after unresolved concerns about duplicated before-and-after images; conclusions no longer considered reliable. Cited in S1's discussion, not one of its nine included studies. FULL reading of the notice.

[S4] A survey on the cosmetic use of injectable polynucleotide: The pattern of practice among Korean dermatologists. J Cosmet Dermatol. 2024;23(4):1243-1252 (online 2023). ↗

2023 · DOI: 10.1111/jocd.16125

Survey of 235 Korean board-certified dermatologists: 88% use PN; three sessions four weeks apart most often recommended; 79% combine with energy devices. Describes practice, not efficacy. ABSTRACT_ONLY.

[S5] Prospective Observational Study of Polynucleotide Injections for Periorbital Rhytides. J Cosmet Dermatol. 2026;25(2):e70736. ↗

2026 · DOI: 10.1111/jocd.70736

Single-clinic observational case series, 42 patients, no control group, product Pluryal Silk 7.5 mg/mL (not Rejuran). Improvement began after the first session, peaked at 3 months after two sessions and eased by 6 months; minimal adverse events; no declared conflicts. PARTIAL review.

一般的規劃與風格資訊,並非診斷、個人化治療建議或結果承諾。臨床問題須由合格的醫師解答。文化上的解讀並不能作為性格或未來的依據。